How Many Physicians Have Opted Out of the Medicare Program?
This brief provides the most recent data on the extent to which non-pediatric physicians are opting out of Medicare, by specialty and by state.
This brief provides the most recent data on the extent to which non-pediatric physicians are opting out of Medicare, by specialty and by state.
Crystalys Therapeutics’ gout drug, dotinurad, inhibits a known and validated target for treating the chronic disorder, but in a way that could be safer than other drugs. The oral small molecule was discovered and developed in Japan, where it is approved and has a safety record spanning more than 1 million gout patients. The post…
CMIO Christopher “Topher” Sharp, M.D., describes the mission of bringing AI into clinical use safely, ethically and cost-effectively
Matt Holt, former New Mountain Capital executive, is exploring a $30 billion deal to combine five health tech startups into a single platform called Thoreau. The venture would set out to simplify and integrate services across payers, providers and data — and if completed, it would rank among the largest private equity-backed health tech companies…
Lynx’s Series A round was led by Flare Capital Partners and included participation from CVS Health Ventures, McKesson Ventures, .406 Ventures, Obvious Ventures and Frist Cressey Ventures. The post Lynx Secures $27M To Simplify Healthcare Payments appeared first on MedCity News.
LOS ANGELES — At Martin Luther King, Jr. Community Hospital, patients on gurneys line the hallways of the emergency department waiting for care, and overflow mental health patients are consigned to outdoor tents. The 152-bed hospital, which sits on a sprawling medical campus close to the predominantly Latino and Black neighborhood of Watts, is struggling…
[Sponsored] Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources. The post The Top 6 Best Analytics Tools for Health Care Revenue in 2025 appeared first on MedCity News.
A BioMarin Pharmaceutical drug met just one of two main goals of a Phase 3 test in a rare inherited enzyme deficiency with no FDA-approved therapies. The drug, a fusion protein, came from BioMarin’s 2025 acquisition of Inozyme Pharma. The post BioMarin’s Mixed Bag of Phase 3 Data Dim Prospects for Rare Disease Drug appeared…
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed on “CBS Mornings Plus” on June 10 how Health and Human Services Secretary Robert F. Kennedy Jr.’s removal of members of the CDC vaccine advisory committee could affect public health. Click here to watch Gounder on “CBS Mornings Plus” Freelance journalist and KFF Health News…
The 15 drugs selected for the Centers for Medicare and Medicaid Services drug price negotiation program accounted for about $27 billion in total prescription spending under Medicare Parts B and D. But this revenue from Medicare makes up a small percentage of each drug manufacturer’s total sales. The post With CMS’s New List of Meds…